Nova Leap Health Corp (TSE:NLH)
TSXV:NLH
Canadian Market

Nova Leap Health (TSE:NLH) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

NLH Analyst Ratings

Moderate Buy
1Ratings
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Nova
Leap Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NLH Stock 12 Months Forecast

Average Price Target

Based on 1 Wall Street analysts offering 12 month price targets for Nova Leap Health in the last 3 months. The average price target is with a high forecast of and a low forecast of . The average price target represents a change from the last price of C$0.25.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NLH Financial Forecast

NLH Earnings Forecast
Next quarter’s earnings estimate for NLH is C$0.03 with a range of C$0.03 to C$0.03. The previous quarter’s EPS was C$0.01. NLH beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.53% of the time in the same period. In the last calendar year NLH has Underperformed its overall industry.
Next quarter’s earnings estimate for NLH is C$0.03 with a range of C$0.03 to C$0.03. The previous quarter’s EPS was C$0.01. NLH beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.53% of the time in the same period. In the last calendar year NLH has Underperformed its overall industry.
NLH Sales Forecast
Next quarter’s sales forecast for NLH is C$9.42M with a range of C$9.42M to C$9.42M. The previous quarter’s sales results were C$9.33M. NLH beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 24.56% of the time in the same period. In the last calendar year NLH has Outperformed its overall industry.
Next quarter’s sales forecast for NLH is C$9.42M with a range of C$9.42M to C$9.42M. The previous quarter’s sales results were C$9.33M. NLH beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 24.56% of the time in the same period. In the last calendar year NLH has Outperformed its overall industry.
NLH Analyst Recommendation Trends
In the current month, NLH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NLH average analyst price target in the past 3 months is ―
In the current month, NLH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NLH average analyst price target in the past 3 months is ―

NLH Stock Forecast FAQ

What is TSE:NLH’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:NLH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:NLH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TSE:NLH a Buy, Sell or Hold?
      Nova Leap Health has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Nova Leap Health’s price target?
        Currently, no data Available
        What do analysts say about Nova Leap Health?
        Nova Leap Health’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis